Both BCMA and CS1 (also known as SLAMF7/CD319) are highly expressed in MMs, with BCMA expressed in all MM cells in virtually all patients [85] whilst CS1 is expressed in > 95% of MMs [86]. The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.